|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mikhail S, Cosgrove D and Zeidan A:
Hepatocellular carcinoma: Systemic therapies and future
perspectives. Expert Rev Anticancer Ther. 14:1205–1218. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baek KK, Kim JH, Uhm JE, Park SH, Lee J,
Park JO, Park YS, Kang WK and Lim HY: Prognostic factors in
patients with advanced hepatocellular carcinoma treated with
sorafenib: A retrospective comparison with previously known
prognostic models. Oncology. 80:167–174. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ikeda M, Morizane C, Ueno M, Okusaka T,
Ishii H and Furuse J: Chemotherapy for hepatocellular carcinoma:
Current status and future perspectives. Jpn J Clin Oncol.
48:103–114. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Skoda AM, Simovic D, Karin V, Kardum V,
Vranic S and Serman L: The role of the Hedgehog signaling pathway
in cancer: A comprehensive review. Bosn J Basic Med Sci. 18:8–20.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang Y, Han C, Lu L, Magliato S and Wu T:
Hedgehog signaling pathway regulates autophagy in human
hepatocellular carcinoma cells. Hepatology. 58:995–1010. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma Y, Yu W, Shrivastava A, Alemi F,
Lankachandra K, Srivastava RK and Shankar S: Sanguinarine inhibits
pancreatic cancer stem cell characteristics by inducing oxidative
stress and suppressing sonic hedgehog-Gli-Nanog pathway.
Carcinogenesis. 38:1047–1056. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Magistri P, Leonard SY, Tang CM, Chan JC,
Lee TE and Sicklick JK: The glypican 3 hepatocellular carcinoma
marker regulates human hepatic stellate cells via Hedgehog
signaling. J Surg Res. 187:377–385. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ke Z, Caiping S, Qing Z and Xiaojing W:
Sonic hedgehog-Gli1 signals promote epithelial-mesenchymal
transition in ovarian cancer by mediating PI3K/AKT pathway. Med
Oncol. 32:3682015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sanchez P, Hernández AM, Stecca B, Kahler
AJ, DeGueme AM, Barrett A, Beyna M, Datta MW, Datta S and Ruiz i
Altaba A: Inhibition of prostate cancer proliferation by
interference with SONIC HEDGEHOG-GLI1 signaling. Proc Natl Acad Sci
USA. 101:12561–12566. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jian-Hui C, Er-Tao Z, Si-Le C, Hui W,
Kai-Ming W, Xin-Hua Z, Chuang-Qi C, Shi-Rong C and Yu-Long H: CD44,
sonic hedgehog, and Gli1 expression are prognostic biomarkers in
gastric cancer patients after radical resection. Gastroenterol Res
Pract. 2016:10130452016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Min S, Xiaoyan X, Fanghui P, Yamei W,
Xiaoli Y and Feng W: The glioma-associated oncogene homolog 1
promotes epithelial-mesenchymal transition in human esophageal
squamous cell cancer by inhibiting E-cadherin via Snail. Cancer
Gene Ther. 20:379–385. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sheng W, Dong M, Zhou J, Li X, Liu Q, Dong
Q and Li F: The clinicopathological significance and relationship
of Gli1, MDM2 and p53 expression in resectable pancreatic cancer.
Histopathology. 64:523–535. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen JS, Huang XH, Wang Q, Huang JQ, Zhang
LJ, Chen XL, Lei J and Cheng ZX: Sonic hedgehog signaling pathway
induces cell migration and invasion through focal adhesion
kinase/AKT signaling-mediated activation of matrix
metalloproteinase (MMP)-2 and MMP-9 in liver cancer.
Carcinogenesis. 34:10–19. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu CH, Lan CT, Chou JF, Tseng TJ and Liao
WC: CHSY1 promotes aggressive phenotypes of hepatocellular
carcinoma cells via activation of the hedgehog signaling pathway.
Cancer Lett. 403:280–288. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guo D, Zhang D, Ren M, Lu G, Zhang X, He S
and Li Y: THBS4 promotes HCC progression by regulating ITGB1 via
FAK/PI3K/AKT pathway. FASEB J. Jun 22–2020.(Epub ahead of print).
View Article : Google Scholar
|
|
18
|
Tokunaga E, Oki E, Egashira A, Sadanaga N,
Morita M, Kakeji Y and Maehara Y: Deregulation of the Akt pathway
in human cancer. Curr Cancer Drug Targets. 8:27–36. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen HC, Appeddu PA, Isoda H and Guan JL:
Phosphorylation of tyrosine 397 in focal adhesion kinase is
required for binding phosphatidylinositol 3-kinase. J Biol Chem.
271:26329–26334. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen JS, Huang XH, Wang Q, Chen XL, Fu XH,
Tan HX, Zhang LJ, Li W and Bi J: FAK is involved in invasion and
metastasis of hepatocellular carcinoma. Clin Exp Metastasis.
27:71–82. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cance WG, Harris JE, Iacocca MV, Roche E,
Yang X, Chang J, Simkins S and Xu L: Immunohistochemical analyses
of focal adhesion kinase expression in benign and malignant human
breast and colon tissues: Correlation with preinvasive and invasive
phenotypes. Clin Cancer Res. 6:2417–2423. 2000.PubMed/NCBI
|
|
22
|
Owens LV, Xu L, Craven RJ, Dent GA, Weiner
TM, Kornberg L, Liu ET and Cance WG: Overexpression of the focal
adhesion kinase (p125FAK) in invasive human tumors. Cancer Res.
55:2752–2755. 1995.PubMed/NCBI
|
|
23
|
Owens LV, Xu L, Dent GA, Yang X, Sturge
GC, Craven RJ and Cance WG: Focal adhesion kinase as a marker of
invasive potential in differentiated human thyroid cancer. Ann Surg
Oncol. 3:100–105. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tremblay L, Hauck W, Aprikian AG, Begin
LR, Chapdelaine A and Chevalier S: Focal adhesion kinase (pp125FAK)
expression, activation and association with paxillin and p50CSK in
human metastatic prostate carcinoma. Int J Cancer. 68:164–171.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ayaki M, Komatsu K, Mukai M, Murata K,
Kameyama M, Ishiguro S, Miyoshi J, Tatsuta M and Nakamura H:
Reduced expression of focal adhesion kinase in liver metastases
compared with matched primary human colorectal adenocarcinomas.
Clin Cancer Res. 7:3106–3112. 2001.PubMed/NCBI
|
|
26
|
Xia H, Nho RS, Kahm J, Kleidon J and Henke
CA: Focal adhesion kinase is upstream of phosphatidylinositol
3-kinase/Akt in regulating fibroblast survival in response to
contraction of type I collagen matrices via a beta 1 integrin
viability signaling pathway. J Biol Chem. 279:33024–33034. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
29:e452001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen B and Hu Z, Li B, Lin X, Luo Z and Hu
Z: The expressions of Hedgehog and PI3K-AKT pathway components
correlate with invasion and metastasis in hepatocellular carcinoma.
Int J Clin Exp Pathol. 12:2381–2388. 2019.PubMed/NCBI
|
|
29
|
Yamamoto H, Itoh F, Adachi Y, Sakamoto H,
Adachi M, Hinoda Y and Imai K: Relation of enhanced secretion of
active matrix metalloproteinases with tumor spread in human
hepatocellular carcinoma. Gastroenterology. 112:1290–1296. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: Regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Coussens LM, Fingleton B and Matrisian LM:
Matrix metalloproteinase inhibitors and cancer: Trials and
tribulations. Science. 295:2387–2392. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Stetler-Stevenson WG: Type IV collagenases
in tumor invasion and metastasis. Cancer Metastasis Rev. 9:289–303.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vihinen P and Kähäri VM: Matrix
metalloproteinases in cancer: Prognostic markers and therapeutic
targets. Int J Cancer. 99:157–166. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hadler-Olsen E, Winberg JO and
Uhlin-Hansen L: Matrix metalloproteinases in cancer: Their value as
diagnostic and prognostic markers and therapeutic targets. Tumour
Biol. 34:2041–2051. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Parnham A and Bousfield C: The influence
of matrix metalloproteases and biofilm on chronic wound healing: A
discussion. Br J Community Nurs. 23 (Suppl 3):S22–S29. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim SA, Kwon SM, Kim JA, Kang KW, Yoon JH
and Ahn SG: 5′-Nitro-indirubinoxime, an indirubin derivative,
suppresses metastatic ability of human head and neck cancer cells
through the inhibition of Integrin β1/FAK/Akt signaling. Cancer
Lett. 306:197–204. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang R, Yu Z, Chen F, Xu H, Shen S, Chen
W, Chen L, Su Q, Zhang L, Bi J, et al: miR-300 regulates the
epithelial-mesenchymal transition and invasion of hepatocellular
carcinoma by targeting the FAK/PI3K/AKT signaling pathway. Biomed
Pharmacother. 103:1632–1642. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cheng JC, Chou CH, Kuo ML and Hsieh CY:
Radiation-enhanced hepatocellular carcinoma cell invasion with
MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction
pathway. Oncogene. 25:7009–7018. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shukla S, Maclennan GT, Hartman DJ, Fu P,
Resnick MI and Gupta S: Activation of PI3K-Akt signaling pathway
promotes prostate cancer cell invasion. Int J Cancer.
121:1424–1432. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li H, Zhang Y, Hai J, Wang J, Zhao B, Du L
and Geng X: Knockdown of TRIM31 suppresses proliferation and
invasion of gallbladder cancer cells by down-regulating MMP2/9
through the PI3K/Akt signaling pathway. Biomed Pharmacother.
103:1272–1278. 2018. View Article : Google Scholar : PubMed/NCBI
|
